.Merck defeats profits requirements, rears sales overview on powerful need for top medicines like Keytruda CNBCMerck & Co. (MRK US) Trumps Earnings Projections as Keytruda Sales Growth BloombergMerck Sell: Pharma Titan Posts Tough Outcomes, But Expectation Falls Short Client's Business DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck trumps income and purchases expectations amid Keytruda strong point, yet supplies combined full-year outlook MarketWatch.